Sky View Investment Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History
Sky View Investment Advisors, LLC
- $602 Million
- Q3 2024
A detailed history of Sky View Investment Advisors, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Sky View Investment Advisors, LLC holds 20,000 shares of IOVA stock, worth $152,000. This represents 0.03% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$152,000% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
313Shares Held
237MCall Options Held
3.77MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA27.3MShares$208 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY26.6MShares$202 Million6.53% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$182 Million28.52% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$161 Million0.0% of portfolio
-
State Street Corp Boston, MA13.2MShares$100 Million0.01% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.2B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...